The effects of neuromuscular blocking agents on mitochondria. IV. Effects of d-tubocurarine, pyrrolizidine alkaloids and magnesium on oxidative phosphorylation.
D000251:Adenosine Triphosphatases / Q000378:metabolism; D000470:Alkaloids / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000818:Animals; D003864:Depression, Chemical; D004492:Edetic Acid / Q000494:pharmacology; D008274:Magnesium / Q000378:metabolism* / Q000494:pharmacology; D008297:Male; D008365:Manometry; D008930:Mitochondria, Liver / Q000187:drug effects / Q000378:metabolism*; D009243:NAD / Q000378:metabolism; D010084:Oxidation-Reduction; D010085:Oxidative Phosphorylation / Q000187:drug effects*; D010101:Oxygen Consumption / Q000187:drug effects; D051381:Rats; D013057:Spectrum Analysis; D013997:Time Factors; D014403:Tubocurarine / Q000494:pharmacology*
D000470:Alkaloids; D009243:NAD; D004492:Edetic Acid; D000251:Adenosine Triphosphatases; D008274:Magnesium; D014403:Tubocurarine